M6 metabolite contributes to the efficacy of the Rac/Cdc42 inhibitor MBQ-167 in metastatic breast cancer.
M6 代谢物有助于 Rac/Cdc42 抑制剂 MBQ-167 在转移性乳腺癌中的疗效。
期刊:Molecular Cancer Therapeutics
影响因子:5.5
doi:10.1158/1535-7163.MCT-25-1319
Grafals-Ruiz Nilmary, Medina Julia I, Colon Gonzalez Jessica, Torres-Sanchez Anamaris, Martin-Ortiz Karla M, Vlaar Cornelis P, Duconge Jorge, Rodriguez-Orengo Jose, Dharmawardhane Suranganie
